Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma

Published:2022-12-09 Issue:6 Volume:200 Page:722-730
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Berenson James R.¹²³^ORCID,Martinez Daisy²,Safaie Tahmineh²,Boccia Ralph⁴,Yang Honghao⁵,Moezi Mehdi⁶,Lim Stephen⁷,Schwartz Gary³,Eshaghian Shahrooz⁸,Swift Regina³,Eades Benjamin M.³,Bujarski Sean³,Regidor Bernard³,Kim Clara²,Kim Susanna²,Vescio Robert⁷

Affiliation:

1. Institute for Myeloma and Bone Cancer Research West Hollywood California USA

2. Oncotherapeutics West Hollywood California USA

3. Berenson Cancer Center West Hollywood California USA

4. Center for Cancer and Blood Disorders Bethesda Maryland USA

5. Global Oncology Alhambra California USA

6. Cancer Specialists of North Florida Fleming Island Florida USA

7. Cedars‐Sinai Samuel Oschin Cancer Center Los Angeles California USA

8. Compassionate Oncology Medical Group Los Angeles California USA

Funder

Incyte

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18593

Reference30 articles.

1. Cancer Statistics, 2021

2. Multiple myeloma

3. Janus kinase inhibitors for the treatment of myeloproliferative neoplasms

4. The role of JAK2 inhibition in polycythemia vera. Target;Mascarenhas J;Oncologia,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma;Oncotarget;2024-02-05

2. Case report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1/JAK2 inhibition;Frontiers in Immunology;2024-01-29

3. Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling;Frontiers in Oncology;2023-10-02

4. Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications;Current Oncology;2023-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3